Abstract
A patient presented with late onset disseminated nontuberculous mycobacterium (NTM) infection due to a novel interleukin-12/interleukin-23 receptor β1 (IL-12/IL-23Rβ1) mutation, r.1561C>G, leading to the amino acid substitution R521G. This is the second patient reported with a partial IL-12/IL-23Rβ1 defect. © 2012 Elsevier Inc.
Original language | English |
---|---|
Pages (from-to) | 83-86 |
Number of pages | 3 |
Journal | Clinical Immunology |
Volume | 144 |
Issue number | 2 |
DOIs | |
Publication status | Published - Aug 2012 |
Keywords
- Interleukin-12/23 receptor β1 deficiency
- Nontuberculous mycobacteria
- Type-1 cytokine pathway